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RT-CT and 17 months and 67% for Hypo-RT-CT+LDRT (Fig 1). 
In Hypo-RT-CT and Hypo-RT-CT+LDRT study median PFS were 




Conclusions: LDFRT combined to Temozolomide and 
hypofractionated radiation therapy is a tolerable schedule. It 
seems to improve outcomes when compared to 
hypofractionated schedule with higher dose. We have 
planned a new study in which Hypo-RT-CT is combined with 
LDRT.  
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Purpose/Objective: The feasibility assessment of the in vivo 
multivoxel magnetic resonance spectroscopy (MRS) focused 
on a hippocampal region as the new approach of the study of 
a postradiation cognitive impairment in patients with brain 
metastases (BM) treated by the whole brain radiotherapy 
(WBRT). 
Materials and Methods: 10 patients (6 with lung, 3 with 
breast cancer and 1 with malignant melanoma) with BM 
(median 3 BM, no lesion within 5mm of hippocampus) get 
WBRT (2 laterolateral fields, 3000 cGy in 10 fraction) as part 
of palliative management. Four months after irradiation, 
patients underwent multivoxel MRS (Siemens Symphony, 
1.5T, PRESS-CSI sequence with TE/TR =135 ms/1690 ms, 12 
averages, FOV 120×120 mm). One region of interest was 
placed centrically to cover the whole mesial parts of the both 
temporal lobes with a voxel layer inclined alongside the 
hippocampal long axis in order to examine whole hippocampi 
volume (voxel size set to 10x10x15mm). Postprocessing of 
raw spectroscopic data was performed utilizing LCModel 
(Provencher et al. 2001) for calculation of N-acetylaspartate 
together with N-acetyl aspartylglutamate (tNAA). tNAA are 
ones of commonly detectable brain tissue metabolites that 
are considered as the markers of neuronal density and 
viability. jSIPRO software (Jiru et al., 2013) was utilized for 
final analysis and measurement of tNAA concentration in the 
both hippocampi and separately its anterior and posterior 
portion. 
Results: Using jSIPRO software, it was possible to evaluate 
tNAA concentrations within selected voxels representing the 
hippocampi at overlaid axial T2 image. On average 12 voxels 
were identified within each hippocampus, however, because 
of noise artifacts, 8-11 representative voxels per 
hippocampus were suitable for the concentration analysis. 
Poor-quality spectroscopic data are related especially to the 
anterior parts of the hippocampus because of the diverse 
magnetic susceptibility of surrounding fluid and bony tissues. 
Conclusions: Besides classical singlevoxel MRS, multivoxel 
hippocampal spectroscopic imaging is feasible and well 
tolerated advanced MRI method for the examination of the 
hippocampus in patients after WBRT. For the proper 
calculation of particular metabolites, reading software 
enabling individual voxels selection is necessary since MRS 
from the parts of the anterior hippocampus in the proximity 
of lateral ventricles and bones are biased as proven in our 
study. Care must be taken in selection representative voxels. 
Basic research focusing on metabolite changes within the 
hippocampus after WBRT may bring more light into processes 
responsible for a brain radiation injury. Such results may 
provide more evidence for special approaches leading to a 
brain injury preservation as is currently widely discussed in 
the hippocampal avoidance whole brain radiotherapy or in a 
pharmacotherapy by memantine for example. 
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